Graham is the Co-Founder and CEO of Kyruus where he has led the development and commercialization of the company’s market-leading patient access platform that now serves over 225,000 providers and 500 hospitals. Prior to Kyruus, Graham was a Venture Executive at Highland Capital Partners where he co-founded Generation Health, a genetic benefit management company that facilitates optimal utilization of genetic testing, and served as the company’s Chief Medical Officer through its acquisition by CVS Caremark. Graham completed his clinical training in internal medicine and cardiology at Beth Israel Deaconess Medical Center and Harvard Medical School, where he also served as Chief Medical Resident. Graham completed his BA and MD degrees at Brown University and earned an MBA from Harvard Business School. He serves as a board member at both Sigma Surgical and Sensory Cloud, as well as an advisor to the Innovation & Digital Health Accelerator at Boston Children’s Hospital and a member of the Digital Health Council of the Massachusetts eHealth Institute.
Tina Brown-Stevenson was SVP, Healthcare Analytics & Decision Support for UnitedHealthcare Networks until 2019. She was charged with assessing and producing advanced analytics to deliver network configurations that support quality and cost effective care delivery. Until mid-2012, Brown-Stevenson was Chief Data and Analytics Officer for Ingenix (renamed Optum Insight), another UnitedHealth Group subsidiary. Prior to that, she was EVP of the Health Care Innovation and Information Group there. Before Ingenix, Brown-Stevenson was President of Aetna Informatics, Aetna’s data, information, and analytics organization. Before joining Aetna in 2001, she served as VP of HealthCare Economics at Cigna, VP of Health System Development at Partners, and VP for Medical Management at UnitedHealthcare of New England.
Brown-Stevenson is a Certified Managed Care executive who received an MA degree in Health Administration from Framingham State College (renamed Framingham State University) and a BS degree in Nursing from the University of Massachusetts at Amherst. She completed post-graduate work in health informatics and is a frequent guest lecturer on managed care and applied health services research.
Brown-Stevenson is a member of the board of trustees of the CT Children’s Medical Center, and the Commonwealth Honors College Advisory Board at the University of Massachusetts at Amherst. She is a former board member of the UnitedHealth Foundation, the Aurora Foundation for Women and Girls, the Aetna Foundation, and the CT Health Foundation. In 2010, her contributions to healthcare earned her national recognition in the annual “Women Worth Watching®” issue of the Profiles in Diversity Journal, dedicated to highlighting women leaders who make a difference.
As CEO of Echo Health Ventures, Rob leads the company's efforts to identify, invest in and grow innovative companies that enable and deliver a transformed experience to health care consumers nationwide. As part of Echo's unique partnership with its parents, Rob works closely with the senior management teams and board of Cambia Health Solutions and Mosaic Health Solutions to support collaboration with Echo's portfolio companies, accelerate Cambia and Mosaic's strategies and more quickly bring health care innovation to national scale.
Rob has more than 20 years of experience in healthcare venture capital and business building. Before founding Echo, Rob served as the President of Cambia Health Solutions' diversified business unit (Direct Health Solutions). In this role, Rob oversaw Cambia's wholly-owned operating companies as well as its venture and private equity investing activities. Rob joined Cambia in 2010 to launch and build the company's diversification and corporate venture investment efforts. Under Rob’s leadership, Cambia invested in nearly 20 companies. In 2015, Rob co-founded the Cambia Grove - an innovation hub focused on catalyzing and supporting the Pacific Northwest’s emerging health care economic cluster.
Before joining Cambia, Rob was the founding partner of Faultline Ventures, where he worked with numerous early stage companies and strategic investors. Previously, he was a Partner at Capitol Health Partners, a Washington, D.C., and New York City-based venture capital firm specializing in early-stage health services and health care information technology.
Active in industry and community organizations, Rob serves on the boards of several health care companies, the board of the Cambia Health Foundation, and as co-chair of the Health Executives Network. He is a founder and former director of the Nashville-based largest network of young health care executives, Leadership Health Care. Rob is a graduate of Georgetown University with a degree in history and is a Chartered Financial Analyst, charter holder.
Former CEO, Partners in Health and Partners HealthCare
Dr. Gary Gottlieb most recently served as CEO of Partners in Health up until June 2019. Prior to that, from 2010 until 2015, he served as president and CEO of Partners HealthCare, the parent of the Brigham and Women’s and Massachusetts General Hospitals, operating the largest health care delivery organization in New England and among the nation’s largest nonprofit biomedical research and training enterprises. Dr. Gottlieb is a professor of psychiatry at Harvard Medical School and a member of the Institute of Medicine of the National Academies. He served as president of Brigham and Women’s/Faulkner Hospitals, as president of North Shore Medical Center, and as chairman of Partners Psychiatry. Prior to coming to Boston, Dr. Gottlieb spent 15 years in positions of increasing leadership in health care in Philadelphia. As a Robert Wood Johnson Foundation Clinical Scholar at the University of Pennsylvania, he earned an M.B.A with distinction in health care administration from the Wharton Graduate School of Business Administration. Dr. Gottlieb is a member of the National Academy of Medicine and serves on the Board of the Federal Reserve Bank of Boston.
Exec. Advisor / Op. Partner, New Mountain Capital | Former President, athenahealth
Dr. Kahane is an executive advisor / operating partner at New Mountain Capital, working directly with select portfolio companies including Ciox Health, Cloudmed. and Signify Health. Previously, he served as EVP and President, Client Organization at athenahealth. During his eight years there, the company grew revenues from $250M to over $1.4B and market cap from under $1B to almost $6B. Prior to that, Dr. Kahane was Chairman and CEO of publicly traded AMICAS, Inc., an image and information management solutions company (acquired by Merge Healthcare). He also served as CEO of publicly traded VitalWorks Inc. (acquired by Cerner) and privately held Datamedic Holding Corporation (acquired by Infocure).
Dr. Kahane has extensive private equity and venture capital experience, including serving as an operating/venture partner at both Bessemer Venture Partners and SV Life Sciences. In addition to Kyruus, he serves as a board member at RevInt/Cloudmed, EarlySense, RevSpring, and Groups Recover Together. He has also served on the boards of Cressy, Homecare Homebase, and RedBrick Health.
Early in his career, Dr. Kahane served as medical director and system development director of IT at Johns Hopkins Medical Institution and was on the faculty of the medical school. He completed his residency and received his M.S. in computer science from Johns Hopkins and his M.D. from Emory University. Dr. Kahane has been married to Christine for 38+ years – they have five children and live in Boston, MA.
EVP, Chief Digital Officer, Providence & Managing General Partner, Providence Ventures
Aaron Martin is responsible for digital, mobile and online marketing at Providence, a not-for-profit health system that combines Providence Health & Services and St. Joseph Health, together comprising 106,000 caregivers across 50 hospitals and 829 clinics. He is also responsible for early stage/venture tech. and medical device investments for PV’s $150M fund, serving on the boards of portfolio companies AVIA and Kyruus. Prior to PSJH, Aaron worked for Amazon and McKinsey, and was an executive/founder of two tech companies. At Amazon, he led CreateSpace before running the Kindle North American Trade business.
Dan joined Highland in 1996 as a Partner to establish and build the firm’s internet investment practice. He is leading the firm’s expansion efforts into China. He continues to be an active investor focusing on technology and consumer investments with specific experience and interest in internet, digital marketing and media technologies. Dan has led the firm’s investments and served on the boards of a number of successful companies including: Amp Resources (acquired by Enel), Ask Jeeves (IPO), BeFree (IPO), Coremetrics (acquired by IBM), eToys (IPO), Fastclick (IPO, acquired by ValueClick), Gamesville (acq'd by Lycos), Lycos (IPO), MapQuest (IPO, acquired by AOL), N2 Broadband (acquired by TANDBERG), Navic Networks (acquired by Microsoft), NextCard (IPO), NYTimes Digital (acquired by New York Times), Qihoo 360 (IPO), Quote.com (acquired by Lycos), Raindance (IPO), RoweCom (IPO), StyleFeeder (acquired by Time, Inc.) and YogaWorks (acquired by Great Hill Partners). His current portfolio includes Beyond the Rack, CMI Marketing, HourlyNerd, Rent The Runway, ThredUp, and Yipit. Dan has been recognized by the prestigious Forbes Midas List as one of the top venture capitalists in the industry. Prior to joining Highland in 1996, Dan was a Partner at CMG@Ventures where he co-led the partnership's investment activities in early-stage internet companies. Dan earned a B.S., Computer Science and Marketing from Boston College and an M.B.A. from Harvard Business School.
Ezra Perlman is a Co-President at Francisco Partners, one of the largest and most active technology-focused private equity firms in the world. He is based in the firm’s San Francisco office and his primary investment focus is on the healthcare technology industry. Ezra currently serves on the board of directors of Avalon Healthcare, eSolutions, HealthcareSource, Kyruus, Landmark Health, QGenda, and Renaissance. Prior to joining Francisco Partners in 2003, Ezra was a venture capitalist with Battery Ventures, where he was involved in identifying, executing and managing private equity investments in software companies. He received an A.B. in Applied Mathematics from Harvard College and an M.B.A. from the Stanford Graduate School of Business.
Bryan is a Partner at Venrock, joining the firm as a Kauffman Fellow in 1997. He is based in Venrock’s Palo Alto office and focuses on a broad range of health care investments. Bryan is currently Chairman of the Board of Directors of Achaogen, Castlight Health, and Ironwood Pharmaceuticals (NASDAQ: IRWD) and also serves on the Board of several other private companies, including Coderyte, Intarcia, Kyruus and Tandem Diagnostics. Past investments include athenahealth (NASDAQ: ATHN), Illumina (NASDAQ: ILMN), Sirna Therapeutics (acquired by Merck) and Xenoport (NASDAQ: XNPT). Bryan was named a Henry Crown Fellow by the Aspen Institute in 2006 and has been the highest-ranking health care investor on Forbes’ Midas List since 2008. Immediately prior to joining Venrock, Bryan received his Ph.D. in Chemistry & Chemical Biology from Harvard University. He previously held positions in corporate finance at Kidder, Peabody & Co and received his B.A. from Dartmouth College.
Vijay Lathi is a Managing Director focused on information convergence and diagnostics investments. Vijay joined Sprout in 1998, was promoted to Partner in 2003, and was one of the founders of New Leaf in 2005. Prior to focusing on information convergence, Vijay’s investment activity covered a range of healthcare technologies including HCIT, diagnostics and therapeutic platforms, and was the founding investor in both Ilypsa (sold to Amgen) and Relypsa (RLYP). Prior to joining Sprout, Vijay was an analyst in the Healthcare Venture Capital Group at Robertson Stephens & Co. and analyst at Cornerstone Research, a consulting firm focused on financial and economic analysis for business litigation. Vijay graduated from the Massachusetts Institute of Technology and Stanford University where he received his B.S. and M.S. in Chemical Engineering, with an emphasis on the application of engineering to life science technology.
Robert Paull is Co-Founder of Lux Capital and focuses on ventures in healthcare. Robert graduated from the University of Virginia and has been a member of the Regional Selection Committee for UVA’s Jefferson Scholars Foundation. Robert was also a member of Motorola’s Research Visionary Board and an invited lecturer at the Memorial Sloan-Kettering Cancer Center, the National Cancer Institute, Yale University, Georgetown, and the University of Virginia. He has been published in Journal of Biomedical Materials Research (Applied Biomaterials) and Nature Biotechnology. Robert was Founding CEO and is currently on the Board of Directors at Harvard Medical School spinout Genocea Biosciences (vaccine discovery). In 2009, Robert was nominated as Biotech CEO of the Year at the World Vaccine Congress. In 2010, Robert was selected as one of the “100 of the Most Inspiring People” by PharmaVoice Magazine. Robert is Co-Founder of Lux Research (emerging technology research), Founding CEO of Kala Pharmaceuticals (mucosal drug delivery), and has served as an Advisor to the Bill & Melinda Gates Foundation.